Evidence map›Paper›PMID 30206190›Full record

ArticleEMBO reports2018

Single-cell transcriptomics reveals distinct inflammation-induced microglia signatures.

Carole Sousa, Anna Golebiewska, Suresh K Poovathingal, Tony Kaoma, Yolanda Pires-Afonso, Silvia Martina, Djalil Coowar, Francisco Azuaje, Alexander Skupin, Rudi Balling and 3 more

Abstract read
In one paragraph

Article in EMBO reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 175 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
175citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

175 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

115 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Carole SousaNORLUX Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg.
Anna GolebiewskaNORLUX Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg.
Suresh K PoovathingalLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-Belval, Luxembourg.
Tony KaomaProteome and Genome Research Unit, Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg.
Yolanda Pires-AfonsoNORLUX Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg.
Silvia MartinaLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-Belval, Luxembourg.
Djalil CoowarLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-Belval, Luxembourg.
Francisco AzuajeProteome and Genome Research Unit, Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg.
Alexander SkupinLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-Belval, Luxembourg.
Rudi BallingLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-Belval, Luxembourg.
Knut BiberSection Molecular Psychiatry, Department for Psychiatry and Psychotherapy, Laboratory of Translational Psychiatry, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID 0000-0002-8815-1705
Simone P NiclouNORLUX Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg.ORCID 0000-0002-3417-9534
Alessandro MichelucciNORLUX Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg alessandro.michelucci@lih.lu.ORCID 0000-0003-1230-061X

Funding

National Biomedical Computation Resource - Competitive Revision SupplementP41GM103426 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AMARO, ROMMIE E · 2012 to 2019
$14.0M
NIGMS NIH HHS P41 GM103426
6 · The paper itself

Abstract

Microglia are specialized parenchymal-resident phagocytes of the central nervous system (CNS) that actively support, defend and modulate the neural environment. Dysfunctional microglial responses are thought to worsen CNS diseases; nevertheless, their impact during neuroinflammatory processes remains largely obscure. Here, using a combination of single-cell RNA sequencing and multicolour flow cytometry, we comprehensively profile microglia in the brain of lipopolysaccharide (LPS)-injected mice. By excluding the contribution of other immune CNS-resident and peripheral cells, we show that microglia isolated from LPS-injected mice display a global downregulation of their homeostatic signature together with an upregulation of inflammatory genes. Notably, we identify distinct microglial activated profiles under inflammatory conditions, which greatly differ from neurodegenerative disease-associated profiles. These results provide insights into microglial heterogeneity and establish a resource for the identification of specific phenotypes in CNS disorders, such as neuroinflammatory and neurodegenerative diseases.

Indexed as

AnimalsCD11b AntigenEncephalitisFemaleFlow CytometryGene Expression RegulationHomeostasisInflammationLeukocyte Common AntigensLipopolysaccharidesMaleMice, Inbred C57BLMicrogliaNeurodegenerative DiseasesSequence Analysis, RNASingle-Cell AnalysisCD11b AntigenLeukocyte Common AntigensLipopolysaccharidesPtprc protein, mouseheterogeneitylipopolysaccharidemicroglianeuroinflammationsingle‐cell RNA‐seq

Identifiers

PMID30206190
PMCPMC6216255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.